These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21094967)

  • 1. Transmissible gastroenteritis virus (TGEV)-based vectors with engineered murine tropism express the rotavirus VP7 protein and immunize mice against rotavirus.
    Ribes JM; Ortego J; Ceriani J; Montava R; Enjuanes L; Buesa J
    Virology; 2011 Feb; 410(1):107-18. PubMed ID: 21094967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Lactobacillus plantarum NC8 strain expressing porcine rotavirus VP7 induces specific antibodies in BALB/c mice.
    Shonyela SM; Shi C; Yang W; Cao X; Yang G; Wang C
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):707-718. PubMed ID: 33963824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and efficacy in mice of an adenovirus-based bicistronic rotavirus vaccine expressing NSP4 and VP7.
    Xie L; Yan M; Wang X; Ye J; Mi K; Yan S; Niu X; Li H; Sun M
    Virus Res; 2015 Dec; 210():298-307. PubMed ID: 26368053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
    Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus.
    Fiore L; Dunn SJ; Ridolfi B; Ruggeri FM; Mackow ER; Greenberg HB
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1981-8. PubMed ID: 7636478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc.
    Both GW; Lockett LJ; Janardhana V; Edwards SJ; Bellamy AR; Graham FL; Prevec L; Andrew ME
    Virology; 1993 Apr; 193(2):940-50. PubMed ID: 8384761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing S gene from porcine epidemic diarrhea virus and VP7 gene from porcine rotavirus.
    Yin Y; Zhu L; Liu P; Zhao J; Fan Y; Sun X; Xu Z
    Braz J Microbiol; 2019 Jan; 50(1):279-286. PubMed ID: 30637649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of single-round infectious rotavirus with a mutation in the intermediate capsid protein VP6.
    Kotaki T; Kanai Y; Onishi M; Minami S; Chen Z; Nouda R; Nurdin JA; Yamasaki M; Kobayashi T
    J Virol; 2024 Jul; 98(7):e0076224. PubMed ID: 38837379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive protection to bovine rotavirus (BRV) infection induced by a BRV VP8* produced in plants using a TMV-based vector.
    Pérez Filgueira DM; Mozgovoj M; Wigdorovitz A; Dus Santos MJ; Parreño V; Trono K; Fernandez FM; Carrillo C; Babiuk LA; Morris TJ; Borca MV
    Arch Virol; 2004 Dec; 149(12):2337-48. PubMed ID: 15338319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus.
    Torres JM; Alonso C; Ortega A; Mittal S; Graham F; Enjuanes L
    J Virol; 1996 Jun; 70(6):3770-80. PubMed ID: 8648712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Bacillus subtilis-based rotavirus vaccine.
    Lee S; Belitsky BR; Brinker JP; Kerstein KO; Brown DW; Clements JD; Keusch GT; Tzipori S; Sonenshein AL; Herrmann JE
    Clin Vaccine Immunol; 2010 Nov; 17(11):1647-55. PubMed ID: 20810679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
    Liu X; Yang T; Sun QM; Sun MS
    Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing spike genes from porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus.
    Meng F; Ren Y; Suo S; Sun X; Li X; Li P; Yang W; Li G; Li L; Schwegmann-Wessels C; Herrler G; Ren X
    PLoS One; 2013; 8(3):e57468. PubMed ID: 23526943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice.
    Zhou B; Zhang Y; Wang X; Dong J; Wang B; Han C; Yu J; Li D
    Vaccine; 2010 Aug; 28(37):6021-7. PubMed ID: 20637305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human rotavirus chimeric fusion proteins from replicating but non disseminating adenovectors and elicitation of rotavirus-specific immune responses in mice.
    Girard A; Roques E; St-Louis MC; Massie B; Archambault D
    Mol Biotechnol; 2013 Jul; 54(3):1010-20. PubMed ID: 23430460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of VP6 immunogenicity and protective efficacy against rotavirus by VP2 in a genetic immunization.
    Lopez-Guerrero DV; Arias N; Gutierrez-Xicotencatl L; Chihu-Amparan L; González A; Pedroza-Saavedra A; Rosas-Salgado G; Villegas-Garcia JC; Badillo-Godinez O; Fernandez G; Lopez S; Esquivel-Guadarrama F
    Vaccine; 2018 May; 36(22):3072-3078. PubMed ID: 28465094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune responses of pigs after primary inoculation with porcine respiratory coronavirus or transmissible gastroenteritis virus and challenge with transmissible gastroenteritis virus.
    Brim TA; VanCott JL; Lunney JK; Saif LJ
    Vet Immunol Immunopathol; 1995 Sep; 48(1-2):35-54. PubMed ID: 8533315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of passive immunity to porcine respiratory coronavirus to protection against transmissible gastroenteritis virus challenge exposure in suckling pigs.
    Sestak K; Lanza I; Park SK; Weilnau PA; Saif LJ
    Am J Vet Res; 1996 May; 57(5):664-71. PubMed ID: 8723879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.